Skip to main content
TipRanks
Go Ultimate75% OFF

Daniel Giannini Insider Profile

4 Followers

Daniel Giannini, former Director at NxStage Medical, holds 81.39K shares in NxStage Medical (Ticker: NXTM). Most recently, Daniel Giannini Sold 6,449 shares of NxStage Medical on Nov 22, 2016 for an estimated value of $167.42K.

Daniel Giannini's Trading History

NXTM
NxStage Medical
Nov 22, 2016―Informative Sell167.42K$2.44M
NXTM
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Nov 22, 2016Informative Sell$167.42K6,449$25.96-6.20%
Nov 10, 2015Informative Sell$133.84K6,593$20.30-23.70%
Mar 17, 2015Uninformative Sell$194.31K14,000$17.40―
Jan 03, 2014Informative Buy$47.32K14,000$3.38+68.50%
Mar 13, 2013Uninformative Sell$75.47K14,000$11.23―

You May Also Like

Daniel Giannini insider profile FAQ

What is the percentage of profitable transactions made by Daniel Giannini?
The percentage of profitable transactions made by Daniel Giannini is 33%.
What is the average return per transaction made by Daniel Giannini?
The average return per transaction made by Daniel Giannini is 12.80%.
What stocks does Daniel Giannini hold?
Daniel Giannini holds: NXTM stocks.
What was Daniel Giannini’s latest transaction?
Daniel Giannini’s latest transaction was an Informative Sell of $167.42K.
What was Daniel Giannini's most profitable transaction?
Daniel Giannini’s most profitable transaction was an Informative Buy of NXTM stock on January 3, 2014. The return on the trade was 68.50%.
What is Daniel Giannini's role in NxStage Medical?
Daniel Giannini's role in NxStage Medical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.